GS
PFE icon

Girard Securities’s Pfizer PFE Stock Holding History

Girard Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,954
Closed -$372K – 85
2017
Q3 		$372K Sell
10,954
-2,716
-20% -$87.3K 0.33% 68
2017
Q2 		$436K Sell
13,670
-1,010
-7% -$31.9K 0.33% 74
2017
Q1 		$476K Sell
14,680
-4,241
-22% -$134K 0.41% 70
2016
Q4 		$583K Sell
18,921
-2,236
-11% -$68.3K 0.51% 58
2016
Q3 		$680K Buy
21,157
+609
+3% +$20.4K 0.7% 36
2016
Q2 		$688K Buy
20,548
+581
+3% +$18.5K 0.63% 43
2016
Q1 		$565K Buy
19,967
+34
+0.2% +$971 0.56% 48
2015
Q4 		$612K Buy
+19,933
New +$627K 0.61% 48

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Girard Securities's PFE Position: Q4 2017 in Review

Girard Securities sold out of Pfizer (PFE) in Q4 2017, closing a stake of 10,954 shares — an estimated $372K sold.

Girard Securities first reported a position in PFE in Q4 2015 and held it in 8 quarters. The position peaked at $688K in Q2 2016. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Girard Securities reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Girard Securities sold 10,954 Pfizer shares in Q4 2017, an estimated $372K.
  • Girard Securities first reported a position in Pfizer in Q4 2015 and held it in 8 quarters.
  • Girard Securities's Pfizer position peaked at $688K in Q2 2016.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Girard Securities's 13F filing for Q4 2017.